SFS
TMO icon

Strategic Financial Services’s Thermo Fisher Scientific TMO Stock Holding History

Strategic Financial Services’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-355
Closed -$220K – 144
2024
Q3 		$220K Buy
+355
New +$210K 0.01% 136
2024
Q2 		– Sell
-355
Closed -$206K – 136
2024
Q1 		$206K Sell
355
-200
-36% -$112K 0.01% 123
2023
Q4 		$295K Sell
555
-100
-15% -$48.4K 0.02% 105
2023
Q3 		$332K Hold
655
– – 0.03% 101
2023
Q2 		$359K Buy
+655
New +$353K 0.03% 99
2021
Q3 		– Sell
-552
Closed -$278K – 142
2021
Q2 		$278K Hold
552
– – 0.02% 122
2021
Q1 		$252K Buy
552
+16
+3% +$7.64K 0.02% 123
2020
Q4 		$250K Buy
536
+45
+9% +$21.1K 0.02% 124
2020
Q3 		$217K Buy
+491
New +$203K 0.02% 118
2019
Q1 		– Sell
-1,491
Closed -$334K – 139
2018
Q4 		$334K Buy
+1,491
New +$350K 0.05% 114

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Strategic Financial Services's TMO Position: Q4 2024 in Review

Strategic Financial Services sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 355 shares — an estimated $220K sold.

Strategic Financial Services first reported a position in TMO in Q4 2018 and held it in 10 quarters. The position peaked at $359K in Q2 2023. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Strategic Financial Services reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Strategic Financial Services sold 355 Thermo Fisher Scientific shares in Q4 2024, an estimated $220K.
  • Strategic Financial Services first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 10 quarters.
  • Strategic Financial Services's Thermo Fisher Scientific position peaked at $359K in Q2 2023.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Strategic Financial Services's 13F filing for Q4 2024, filed 11 Feb 2025.